BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37682094)

  • 1. [Serum brain damage biomarkers as a diagnostic and prognostic tool in ischemic stroke].
    Chaykovskaya AD; Topuzova MP; Ternovykh IK; Makhanova AM; Mikheeva AG; Pospelova ML; Panina EB; Vavilova TV; Vasilieva EY; Shustova TA; Alekseeva TM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(8. Vyp. 2):37-46. PubMed ID: 37682094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A panel of serum biomarkers, including damage, apoptosis and neurotrophic markers, for the assessment of prognosis of the course of ischemic stroke].
    Chukanova AS; Gulieva MS; Chukanova EI; Bagmanyan SJ
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(8. Vyp. 2):48-53. PubMed ID: 36036143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation.
    Undén J; Strandberg K; Malm J; Campbell E; Rosengren L; Stenflo J; Norrving B; Romner B; Lindgren A; Andsberg G
    J Neurol; 2009 Jan; 256(1):72-7. PubMed ID: 19221847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Blood Biomarkers in Differentiating Ischemic Stroke and Intracerebral Hemorrhage.
    Bhatia R; Warrier AR; Sreenivas V; Bali P; Sisodia P; Gupta A; Singh N; Padma Srivastava MV; Prasad K
    Neurol India; 2020; 68(4):824-829. PubMed ID: 32859821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neuron specific enolase could predict subclinical brain damage and the subsequent occurrence of brain related vascular events during follow up in essential hypertension.
    González-Quevedo A; González-García S; Hernández-Díaz Z; Fernández Concepción O; Quevedo Sotolongo L; Peña-Sánchez M; Márquez Rosales B; Santiesteban Freixas R; Fernández-Almirall I; Menéndez-Sainz MC; Fernández-Carriera R
    J Neurol Sci; 2016 Apr; 363():158-63. PubMed ID: 27000243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GFAP and antibodies against NMDA receptor subunit NR2 as biomarkers for acute cerebrovascular diseases.
    Stanca DM; Mărginean IC; Sorițău O; Dragoș C; Mărginean M; Mureșanu DF; Vester JC; Rafila A
    J Cell Mol Med; 2015 Sep; 19(9):2253-61. PubMed ID: 26081945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau, S100B and NSE as Blood Biomarkers in Acute Cerebrovascular Events.
    Onatsu J; Vanninen R; JÄkÄlÄ P; Mustonen P; Pulkki K; Korhonen M; Hedman M; HÖglund K; Blennow K; Zetterberg H; Herukka SK; Taina M
    In Vivo; 2020; 34(5):2577-2586. PubMed ID: 32871787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A literature review of the feasibility of glial fibrillary acidic protein as a biomarker for stroke and traumatic brain injury.
    Schiff L; Hadker N; Weiser S; Rausch C
    Mol Diagn Ther; 2012 Apr; 16(2):79-92. PubMed ID: 22497529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.
    Vos PE; Lamers KJ; Hendriks JC; van Haaren M; Beems T; Zimmerman C; van Geel W; de Reus H; Biert J; Verbeek MM
    Neurology; 2004 Apr; 62(8):1303-10. PubMed ID: 15111666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
    Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
    J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-cardiac arrest serum levels of glial fibrillary acidic protein for predicting neurological outcome.
    Larsson IM; Wallin E; Kristofferzon ML; Niessner M; Zetterberg H; Rubertsson S
    Resuscitation; 2014 Dec; 85(12):1654-61. PubMed ID: 25260722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning.
    Akdemir HU; Yardan T; Kati C; Duran L; Alacam H; Yavuz Y; Okuyucu A
    Hum Exp Toxicol; 2014 Nov; 33(11):1113-20. PubMed ID: 24505052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Investigating Neuron-Specific Enolase in Patients with Ischemic Stroke.
    Kurakina АS; Semenova TN; Guzanova EV; Nesterova VN; Schelchkova NA; Mukhina IV; Grigoryeva VN
    Sovrem Tekhnologii Med; 2021; 13(2):68-72. PubMed ID: 34513079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase.
    Honda M; Tsuruta R; Kaneko T; Kasaoka S; Yagi T; Todani M; Fujita M; Izumi T; Maekawa T
    J Trauma; 2010 Jul; 69(1):104-9. PubMed ID: 20093985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary neuron specific enolase: an indicator for neuronal damage in patients with ischemic stroke and stroke-prone patients.
    Al-Rawi NH; Atiyah KM
    Clin Chem Lab Med; 2009; 47(12):1519-24. PubMed ID: 19877764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurospecific proteins and autoantibodies in serum of patients with acute ischemic stroke].
    Kamchatov PR; Ruleva NIu; Dugin SF; Buriachkovskaia LI; Chugunov AV; Mikhaĭlova NA; Basse DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5 Suppl 2):69-72. PubMed ID: 19894304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNAs versus protein biomarkers to diagnose and differentiate acute stroke: Systematic review and meta-analysis.
    Florijn BW; Leontien van der Bent M; Nguyen TMT; Quax PHA; Wermer MJH; Yaël Nossent A; Kruyt ND
    J Stroke Cerebrovasc Dis; 2023 Nov; 32(11):107388. PubMed ID: 37778160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke.
    Foerch C; Niessner M; Back T; Bauerle M; De Marchis GM; Ferbert A; Grehl H; Hamann GF; Jacobs A; Kastrup A; Klimpe S; Palm F; Thomalla G; Worthmann H; Sitzer M;
    Clin Chem; 2012 Jan; 58(1):237-45. PubMed ID: 22125303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Serum Glial Fibrillary Acidic Protein (GFAP) is Associated with Poor Functional Outcome After Cardiopulmonary Resuscitation.
    Helwig K; Seeger F; Hölschermann H; Lischke V; Gerriets T; Niessner M; Foerch C
    Neurocrit Care; 2017 Aug; 27(1):68-74. PubMed ID: 28054291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red cell distribution width: a novel predictive biomarker for stroke risk after transient ischaemic attack.
    Xie KH; Liu LL; Liang YR; Su CY; Li H; Liu RN; Chen QQ; He JS; Ruan YK; He WK
    Ann Med; 2022 Dec; 54(1):1167-1177. PubMed ID: 35471128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.